nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—Mood swings—Doxorubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Frovatriptan—Asthenia—Thiotepa—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Frovatriptan—Ataxia—Doxorubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Frovatriptan—Dysphagia—Epirubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Frovatriptan—Pruritus—Thiotepa—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Frovatriptan—Pain—Fluorouracil—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Frovatriptan—Dehydration—Doxorubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Frovatriptan—Paraesthesia—Cisplatin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Frovatriptan—Tachycardia—Etoposide—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Frovatriptan—Dyspnoea—Cisplatin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Frovatriptan—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Frovatriptan—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Frovatriptan—Anorexia—Etoposide—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Frovatriptan—Diarrhoea—Thiotepa—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Frovatriptan—Decreased appetite—Cisplatin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Frovatriptan—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Frovatriptan—Depression—Methotrexate—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Frovatriptan—Pain—Cisplatin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Frovatriptan—Muscular weakness—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Frovatriptan—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Frovatriptan—Dizziness—Thiotepa—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Frovatriptan—Stomatitis—Methotrexate—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Frovatriptan—Conjunctivitis—Methotrexate—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Frovatriptan—Dysphagia—Doxorubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Frovatriptan—Pollakiuria—Epirubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Frovatriptan—Body temperature increased—Fluorouracil—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Frovatriptan—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Frovatriptan—Paraesthesia—Etoposide—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Frovatriptan—Dyspnoea—Etoposide—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Frovatriptan—Somnolence—Etoposide—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Frovatriptan—Epistaxis—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Frovatriptan—Vomiting—Thiotepa—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Frovatriptan—Headache—Thiotepa—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Frovatriptan—Decreased appetite—Etoposide—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Frovatriptan—Body temperature increased—Cisplatin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Frovatriptan—Fatigue—Etoposide—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Frovatriptan—Stomatitis—Epirubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Frovatriptan—Pain—Etoposide—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Frovatriptan—Constipation—Etoposide—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Frovatriptan—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Frovatriptan—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Frovatriptan—Haemoglobin—Methotrexate—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Frovatriptan—Haemorrhage—Methotrexate—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Frovatriptan—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Frovatriptan—Asthenia—Gemcitabine—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Frovatriptan—Pharyngitis—Methotrexate—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Frovatriptan—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Epistaxis—Epirubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Frovatriptan—Pruritus—Gemcitabine—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Nausea—Thiotepa—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Urethral disorder—Methotrexate—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Sinusitis—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Feeling abnormal—Etoposide—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Frovatriptan—Pruritus—Fluorouracil—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Frovatriptan—Visual impairment—Methotrexate—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Frovatriptan—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Frovatriptan—Bradycardia—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Frovatriptan—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Frovatriptan—Haemoglobin—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Frovatriptan—Stomatitis—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Frovatriptan—Rhinitis—Epirubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Frovatriptan—Body temperature increased—Etoposide—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Frovatriptan—Abdominal pain—Etoposide—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Frovatriptan—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Frovatriptan—Haemorrhage—Epirubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Frovatriptan—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Frovatriptan—Tinnitus—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Frovatriptan—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Frovatriptan—Asthenia—Cisplatin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Frovatriptan—Pharyngitis—Epirubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Frovatriptan—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Frovatriptan—Urethral disorder—Epirubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Frovatriptan—Epistaxis—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Frovatriptan—Sinusitis—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Frovatriptan—Dizziness—Fluorouracil—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Frovatriptan—Visual impairment—Epirubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Frovatriptan—Chills—Methotrexate—urinary bladder cancer	0.000999	0.000999	CcSEcCtD
Frovatriptan—Diarrhoea—Cisplatin—urinary bladder cancer	0.000987	0.000987	CcSEcCtD
Frovatriptan—Vomiting—Gemcitabine—urinary bladder cancer	0.000984	0.000984	CcSEcCtD
Frovatriptan—Bradycardia—Doxorubicin—urinary bladder cancer	0.000982	0.000982	CcSEcCtD
Frovatriptan—Mental disorder—Methotrexate—urinary bladder cancer	0.000976	0.000976	CcSEcCtD
Frovatriptan—Hypersensitivity—Etoposide—urinary bladder cancer	0.000973	0.000973	CcSEcCtD
Frovatriptan—Tinnitus—Epirubicin—urinary bladder cancer	0.000972	0.000972	CcSEcCtD
Frovatriptan—Malnutrition—Methotrexate—urinary bladder cancer	0.00097	0.00097	CcSEcCtD
Frovatriptan—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000969	0.000969	CcSEcCtD
Frovatriptan—Headache—Gemcitabine—urinary bladder cancer	0.000969	0.000969	CcSEcCtD
Frovatriptan—Flushing—Epirubicin—urinary bladder cancer	0.000967	0.000967	CcSEcCtD
Frovatriptan—Vomiting—Fluorouracil—urinary bladder cancer	0.000967	0.000967	CcSEcCtD
Frovatriptan—Rhinitis—Doxorubicin—urinary bladder cancer	0.000967	0.000967	CcSEcCtD
Frovatriptan—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000965	0.000965	CcSEcCtD
Frovatriptan—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00096	0.00096	CcSEcCtD
Frovatriptan—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000957	0.000957	CcSEcCtD
Frovatriptan—Headache—Fluorouracil—urinary bladder cancer	0.000953	0.000953	CcSEcCtD
Frovatriptan—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000953	0.000953	CcSEcCtD
Frovatriptan—Dysgeusia—Methotrexate—urinary bladder cancer	0.00095	0.00095	CcSEcCtD
Frovatriptan—Asthenia—Etoposide—urinary bladder cancer	0.000948	0.000948	CcSEcCtD
Frovatriptan—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000945	0.000945	CcSEcCtD
Frovatriptan—Back pain—Methotrexate—urinary bladder cancer	0.000938	0.000938	CcSEcCtD
Frovatriptan—Chills—Epirubicin—urinary bladder cancer	0.000935	0.000935	CcSEcCtD
Frovatriptan—Pruritus—Etoposide—urinary bladder cancer	0.000935	0.000935	CcSEcCtD
Frovatriptan—Arrhythmia—Epirubicin—urinary bladder cancer	0.000931	0.000931	CcSEcCtD
Frovatriptan—Visual impairment—Doxorubicin—urinary bladder cancer	0.000929	0.000929	CcSEcCtD
Frovatriptan—Nausea—Gemcitabine—urinary bladder cancer	0.000919	0.000919	CcSEcCtD
Frovatriptan—Vomiting—Cisplatin—urinary bladder cancer	0.000917	0.000917	CcSEcCtD
Frovatriptan—Mental disorder—Epirubicin—urinary bladder cancer	0.000913	0.000913	CcSEcCtD
Frovatriptan—Malnutrition—Epirubicin—urinary bladder cancer	0.000907	0.000907	CcSEcCtD
Frovatriptan—Diarrhoea—Etoposide—urinary bladder cancer	0.000904	0.000904	CcSEcCtD
Frovatriptan—Nausea—Fluorouracil—urinary bladder cancer	0.000904	0.000904	CcSEcCtD
Frovatriptan—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.0009	0.0009	CcSEcCtD
Frovatriptan—Tinnitus—Doxorubicin—urinary bladder cancer	0.000899	0.000899	CcSEcCtD
Frovatriptan—Flushing—Doxorubicin—urinary bladder cancer	0.000895	0.000895	CcSEcCtD
Frovatriptan—Flatulence—Epirubicin—urinary bladder cancer	0.000894	0.000894	CcSEcCtD
Frovatriptan—Tension—Epirubicin—urinary bladder cancer	0.00089	0.00089	CcSEcCtD
Frovatriptan—Dysgeusia—Epirubicin—urinary bladder cancer	0.000889	0.000889	CcSEcCtD
Frovatriptan—Nervousness—Epirubicin—urinary bladder cancer	0.000881	0.000881	CcSEcCtD
Frovatriptan—Back pain—Epirubicin—urinary bladder cancer	0.000878	0.000878	CcSEcCtD
Frovatriptan—Malaise—Methotrexate—urinary bladder cancer	0.000874	0.000874	CcSEcCtD
Frovatriptan—Dizziness—Etoposide—urinary bladder cancer	0.000874	0.000874	CcSEcCtD
Frovatriptan—Muscle spasms—Epirubicin—urinary bladder cancer	0.000872	0.000872	CcSEcCtD
Frovatriptan—Vertigo—Methotrexate—urinary bladder cancer	0.000871	0.000871	CcSEcCtD
Frovatriptan—Chills—Doxorubicin—urinary bladder cancer	0.000865	0.000865	CcSEcCtD
Frovatriptan—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000862	0.000862	CcSEcCtD
Frovatriptan—Nausea—Cisplatin—urinary bladder cancer	0.000857	0.000857	CcSEcCtD
Frovatriptan—Mental disorder—Doxorubicin—urinary bladder cancer	0.000845	0.000845	CcSEcCtD
Frovatriptan—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000842	0.000842	CcSEcCtD
Frovatriptan—Convulsion—Methotrexate—urinary bladder cancer	0.00084	0.00084	CcSEcCtD
Frovatriptan—Vomiting—Etoposide—urinary bladder cancer	0.00084	0.00084	CcSEcCtD
Frovatriptan—Malnutrition—Doxorubicin—urinary bladder cancer	0.00084	0.00084	CcSEcCtD
Frovatriptan—Agitation—Epirubicin—urinary bladder cancer	0.000834	0.000834	CcSEcCtD
Frovatriptan—Headache—Etoposide—urinary bladder cancer	0.000828	0.000828	CcSEcCtD
Frovatriptan—Flatulence—Doxorubicin—urinary bladder cancer	0.000827	0.000827	CcSEcCtD
Frovatriptan—Chest pain—Methotrexate—urinary bladder cancer	0.000826	0.000826	CcSEcCtD
Frovatriptan—Arthralgia—Methotrexate—urinary bladder cancer	0.000826	0.000826	CcSEcCtD
Frovatriptan—Myalgia—Methotrexate—urinary bladder cancer	0.000826	0.000826	CcSEcCtD
Frovatriptan—Tension—Doxorubicin—urinary bladder cancer	0.000824	0.000824	CcSEcCtD
Frovatriptan—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000822	0.000822	CcSEcCtD
Frovatriptan—Malaise—Epirubicin—urinary bladder cancer	0.000818	0.000818	CcSEcCtD
Frovatriptan—Discomfort—Methotrexate—urinary bladder cancer	0.000816	0.000816	CcSEcCtD
Frovatriptan—Nervousness—Doxorubicin—urinary bladder cancer	0.000815	0.000815	CcSEcCtD
Frovatriptan—Vertigo—Epirubicin—urinary bladder cancer	0.000815	0.000815	CcSEcCtD
Frovatriptan—Syncope—Epirubicin—urinary bladder cancer	0.000814	0.000814	CcSEcCtD
Frovatriptan—Back pain—Doxorubicin—urinary bladder cancer	0.000812	0.000812	CcSEcCtD
Frovatriptan—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000807	0.000807	CcSEcCtD
Frovatriptan—Palpitations—Epirubicin—urinary bladder cancer	0.000802	0.000802	CcSEcCtD
Frovatriptan—Confusional state—Methotrexate—urinary bladder cancer	0.000798	0.000798	CcSEcCtD
Frovatriptan—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000798	0.000798	CcSEcCtD
Frovatriptan—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000791	0.000791	CcSEcCtD
Frovatriptan—Convulsion—Epirubicin—urinary bladder cancer	0.000786	0.000786	CcSEcCtD
Frovatriptan—Nausea—Etoposide—urinary bladder cancer	0.000785	0.000785	CcSEcCtD
Frovatriptan—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000779	0.000779	CcSEcCtD
Frovatriptan—Myalgia—Epirubicin—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Frovatriptan—Arthralgia—Epirubicin—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Frovatriptan—Chest pain—Epirubicin—urinary bladder cancer	0.000773	0.000773	CcSEcCtD
Frovatriptan—Agitation—Doxorubicin—urinary bladder cancer	0.000772	0.000772	CcSEcCtD
Frovatriptan—Anxiety—Epirubicin—urinary bladder cancer	0.00077	0.00077	CcSEcCtD
Frovatriptan—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000765	0.000765	CcSEcCtD
Frovatriptan—Discomfort—Epirubicin—urinary bladder cancer	0.000763	0.000763	CcSEcCtD
Frovatriptan—Malaise—Doxorubicin—urinary bladder cancer	0.000757	0.000757	CcSEcCtD
Frovatriptan—Dry mouth—Epirubicin—urinary bladder cancer	0.000756	0.000756	CcSEcCtD
Frovatriptan—Vertigo—Doxorubicin—urinary bladder cancer	0.000754	0.000754	CcSEcCtD
Frovatriptan—Anorexia—Methotrexate—urinary bladder cancer	0.000754	0.000754	CcSEcCtD
Frovatriptan—Syncope—Doxorubicin—urinary bladder cancer	0.000753	0.000753	CcSEcCtD
Frovatriptan—Confusional state—Epirubicin—urinary bladder cancer	0.000747	0.000747	CcSEcCtD
Frovatriptan—Palpitations—Doxorubicin—urinary bladder cancer	0.000742	0.000742	CcSEcCtD
Frovatriptan—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000741	0.000741	CcSEcCtD
Frovatriptan—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000738	0.000738	CcSEcCtD
Frovatriptan—Shock—Epirubicin—urinary bladder cancer	0.000729	0.000729	CcSEcCtD
Frovatriptan—Convulsion—Doxorubicin—urinary bladder cancer	0.000727	0.000727	CcSEcCtD
Frovatriptan—Tachycardia—Epirubicin—urinary bladder cancer	0.000723	0.000723	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000721	0.000721	CcSEcCtD
Frovatriptan—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Frovatriptan—Insomnia—Methotrexate—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Frovatriptan—Chest pain—Doxorubicin—urinary bladder cancer	0.000715	0.000715	CcSEcCtD
Frovatriptan—Arthralgia—Doxorubicin—urinary bladder cancer	0.000715	0.000715	CcSEcCtD
Frovatriptan—Myalgia—Doxorubicin—urinary bladder cancer	0.000715	0.000715	CcSEcCtD
Frovatriptan—Anxiety—Doxorubicin—urinary bladder cancer	0.000712	0.000712	CcSEcCtD
Frovatriptan—Paraesthesia—Methotrexate—urinary bladder cancer	0.000711	0.000711	CcSEcCtD
Frovatriptan—Discomfort—Doxorubicin—urinary bladder cancer	0.000706	0.000706	CcSEcCtD
Frovatriptan—Anorexia—Epirubicin—urinary bladder cancer	0.000706	0.000706	CcSEcCtD
Frovatriptan—Dyspnoea—Methotrexate—urinary bladder cancer	0.000706	0.000706	CcSEcCtD
Frovatriptan—Somnolence—Methotrexate—urinary bladder cancer	0.000704	0.000704	CcSEcCtD
Frovatriptan—Dry mouth—Doxorubicin—urinary bladder cancer	0.000699	0.000699	CcSEcCtD
Frovatriptan—Dyspepsia—Methotrexate—urinary bladder cancer	0.000697	0.000697	CcSEcCtD
Frovatriptan—Confusional state—Doxorubicin—urinary bladder cancer	0.000691	0.000691	CcSEcCtD
Frovatriptan—Decreased appetite—Methotrexate—urinary bladder cancer	0.000688	0.000688	CcSEcCtD
Frovatriptan—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000685	0.000685	CcSEcCtD
Frovatriptan—Fatigue—Methotrexate—urinary bladder cancer	0.000682	0.000682	CcSEcCtD
Frovatriptan—Pain—Methotrexate—urinary bladder cancer	0.000677	0.000677	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000675	0.000675	CcSEcCtD
Frovatriptan—Shock—Doxorubicin—urinary bladder cancer	0.000674	0.000674	CcSEcCtD
Frovatriptan—Insomnia—Epirubicin—urinary bladder cancer	0.00067	0.00067	CcSEcCtD
Frovatriptan—Tachycardia—Doxorubicin—urinary bladder cancer	0.000669	0.000669	CcSEcCtD
Frovatriptan—Paraesthesia—Epirubicin—urinary bladder cancer	0.000665	0.000665	CcSEcCtD
Frovatriptan—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000662	0.000662	CcSEcCtD
Frovatriptan—Dyspnoea—Epirubicin—urinary bladder cancer	0.00066	0.00066	CcSEcCtD
Frovatriptan—Somnolence—Epirubicin—urinary bladder cancer	0.000658	0.000658	CcSEcCtD
Frovatriptan—Anorexia—Doxorubicin—urinary bladder cancer	0.000653	0.000653	CcSEcCtD
Frovatriptan—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000652	0.000652	CcSEcCtD
Frovatriptan—Dyspepsia—Epirubicin—urinary bladder cancer	0.000652	0.000652	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000647	0.000647	CcSEcCtD
Frovatriptan—Decreased appetite—Epirubicin—urinary bladder cancer	0.000644	0.000644	CcSEcCtD
Frovatriptan—Fatigue—Epirubicin—urinary bladder cancer	0.000638	0.000638	CcSEcCtD
Frovatriptan—Pain—Epirubicin—urinary bladder cancer	0.000633	0.000633	CcSEcCtD
Frovatriptan—Constipation—Epirubicin—urinary bladder cancer	0.000633	0.000633	CcSEcCtD
Frovatriptan—Body temperature increased—Methotrexate—urinary bladder cancer	0.000626	0.000626	CcSEcCtD
Frovatriptan—Abdominal pain—Methotrexate—urinary bladder cancer	0.000626	0.000626	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000624	0.000624	CcSEcCtD
Frovatriptan—Insomnia—Doxorubicin—urinary bladder cancer	0.00062	0.00062	CcSEcCtD
Frovatriptan—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000615	0.000615	CcSEcCtD
Frovatriptan—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000611	0.000611	CcSEcCtD
Frovatriptan—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00061	0.00061	CcSEcCtD
Frovatriptan—Somnolence—Doxorubicin—urinary bladder cancer	0.000609	0.000609	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000606	0.000606	CcSEcCtD
Frovatriptan—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000603	0.000603	CcSEcCtD
Frovatriptan—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000596	0.000596	CcSEcCtD
Frovatriptan—Fatigue—Doxorubicin—urinary bladder cancer	0.000591	0.000591	CcSEcCtD
Frovatriptan—Pain—Doxorubicin—urinary bladder cancer	0.000586	0.000586	CcSEcCtD
Frovatriptan—Constipation—Doxorubicin—urinary bladder cancer	0.000586	0.000586	CcSEcCtD
Frovatriptan—Abdominal pain—Epirubicin—urinary bladder cancer	0.000585	0.000585	CcSEcCtD
Frovatriptan—Body temperature increased—Epirubicin—urinary bladder cancer	0.000585	0.000585	CcSEcCtD
Frovatriptan—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000583	0.000583	CcSEcCtD
Frovatriptan—Asthenia—Methotrexate—urinary bladder cancer	0.000568	0.000568	CcSEcCtD
Frovatriptan—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000565	0.000565	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00056	0.00056	CcSEcCtD
Frovatriptan—Pruritus—Methotrexate—urinary bladder cancer	0.00056	0.00056	CcSEcCtD
Frovatriptan—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000546	0.000546	CcSEcCtD
Frovatriptan—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000542	0.000542	CcSEcCtD
Frovatriptan—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000542	0.000542	CcSEcCtD
Frovatriptan—Diarrhoea—Methotrexate—urinary bladder cancer	0.000541	0.000541	CcSEcCtD
Frovatriptan—Asthenia—Epirubicin—urinary bladder cancer	0.000531	0.000531	CcSEcCtD
Frovatriptan—Pruritus—Epirubicin—urinary bladder cancer	0.000524	0.000524	CcSEcCtD
Frovatriptan—Dizziness—Methotrexate—urinary bladder cancer	0.000523	0.000523	CcSEcCtD
Frovatriptan—Diarrhoea—Epirubicin—urinary bladder cancer	0.000507	0.000507	CcSEcCtD
Frovatriptan—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000505	0.000505	CcSEcCtD
Frovatriptan—Vomiting—Methotrexate—urinary bladder cancer	0.000503	0.000503	CcSEcCtD
Frovatriptan—Headache—Methotrexate—urinary bladder cancer	0.000496	0.000496	CcSEcCtD
Frovatriptan—Asthenia—Doxorubicin—urinary bladder cancer	0.000492	0.000492	CcSEcCtD
Frovatriptan—Dizziness—Epirubicin—urinary bladder cancer	0.00049	0.00049	CcSEcCtD
Frovatriptan—Pruritus—Doxorubicin—urinary bladder cancer	0.000485	0.000485	CcSEcCtD
Frovatriptan—Vomiting—Epirubicin—urinary bladder cancer	0.000471	0.000471	CcSEcCtD
Frovatriptan—Nausea—Methotrexate—urinary bladder cancer	0.00047	0.00047	CcSEcCtD
Frovatriptan—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000469	0.000469	CcSEcCtD
Frovatriptan—Headache—Epirubicin—urinary bladder cancer	0.000464	0.000464	CcSEcCtD
Frovatriptan—Dizziness—Doxorubicin—urinary bladder cancer	0.000453	0.000453	CcSEcCtD
Frovatriptan—Nausea—Epirubicin—urinary bladder cancer	0.00044	0.00044	CcSEcCtD
Frovatriptan—Vomiting—Doxorubicin—urinary bladder cancer	0.000436	0.000436	CcSEcCtD
Frovatriptan—Headache—Doxorubicin—urinary bladder cancer	0.000429	0.000429	CcSEcCtD
Frovatriptan—Nausea—Doxorubicin—urinary bladder cancer	0.000407	0.000407	CcSEcCtD
